Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment

Clinica Chimica Acta

Volumn 379, Issue 1-2, 2007, Pages 53-58

  Miettinen, Tatu A ^a   Gylling, Helena ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cholesterol; Coronary artery disease; Glucose; Lathosterol; Plant sterols

Indexed keywords

CHOLESTEROL; GLUCOSE; LATHOSTEROL; SIMVASTATIN; SITOSTEROL; SQUALENE;

ABSORPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CHOLESTANOL; CORONARY DISEASE; FEMALE; HUMANS; MALE; SIMVASTATIN;

EID: 33847649502     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.12.011     Document Type: Article

References (30)

1. Haffner S.M., et al., for the Scandinavian Simvastatin Survival Study Group. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels. Subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med 159 (1999) 2661-2667
2. Pyörälä K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., and Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20 (1997) 614-620
3. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
4. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
5. Tuomilehto J., et al., for the Finnish Diabetes Prevention Study Group. Prevention of type 1 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
6. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
7. Sutherland W.H., Scott R.S., Lintott C.J., Robertson M.C., Stapely S.A., and Cox C. Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. Horm Metab Res 24 (1992) 172-175
8. Gylling H., and Miettinen T.A. Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care 20 (1997) 90-95
9. Simonen P.P., Gylling H.K., and Miettinen T.A. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 25 (2002) 1511-1515
10. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum cholestanol and plan sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 38 (1989) 136-140
11. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131 (1990) 20-31
12. Strandberg T.E., Salomaa V., Vanhanen H., and Miettinen T.A. Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes 45 (1996) 755-761
13. Pihlajamäki J., Gylling H., Miettinen T.A., and Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 45 (2004) 507-512
14. Miettinen T.A., and Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. In: Paumgartner G., Stiehl A., and Gerok W. (Eds). Bile acids and cholesterol in health and disease (1983), MTP Press, Lancaster PA 183-187
15. Miettinen T.A. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29 (1988) 43-51
16. The Scandinavian Simvastatin Survival Study Group. Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction. Am J Cardiol 71 (1993) 393-400
17. Miettinen T.A., et al., for the Finnish 4S Investigators. Baseline noncholesterol sterols and treatment effect in a subgroup of the Scandinavian Simvastatin Survival Study (4S). BMJ 316 (1998) 1127-1130
18. Miettinen T.A. Cholesterol production in obesity. Circulation 44 (1974) 842-850
19. Miettinen T.A., and Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 153 (2000) 241-248
20. Moller D.E., and Flier J.S. Insulin resistance-mechanisms, syndromes and implications. N Engl J Med 325 (1991) 938-948
21. Gylling H., Hallikainen M., Pihlajamäki J., et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 45 (2004) 1660-1665
22. Simonen P., Gylling H., Howard A.N., and Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 72 (2000) 82-88
23. Miettinen T.A. Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor. Eur J Clin Pharmacol 40 Suppl 1 (1991) 19-21
24. Miettinen T.A., Vanhanen H., Ojala J.-P., and Tikkanen M.J. Non-cholesterol sterols and faecal elimination of cholesterol during statin and fibrate treatment. Atherosclerosis 97 (1992) 73-80
25. Miettinen T.A., Gylling H., Lindbohm N., Miettinen T.E., Rajaratnam R.A., and Relas H. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J Lab Clin Med 141 (2003) 131-137
26. Miettinen T.A., and Gylling H. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Investig 33 (2002) 976-982
27. Miettinen T.A., Strandberg T.E., Gylling H., and for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 20 (2000) 1340-1346
28. Nauomova R.P., Marais A.D., Mountney J., et al. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis 119 (1996) 203-213
29. Gylling H., Rajaratnam R., and Miettinen T.A. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation 96 (1997) 4226-4231
30. Davidson M., et al., for the Ezetimibe Study Group. Ezetimibe co-administered with simvastatin in 668 patients with primary hypercholesterolemia. J Am Coll Cardiol Suppl 226A (2002) 1084-1090